Industry P pharmaphorum
Microsoft outage disrupting healthcare; reports
Microsoft outage disrupting healthcare; reports Phil.Taylor Fri, 13/11/2026 - 09:34
Industry headlines from across biotech and life sciences, gathered from the industry press and linked straight to the publisher. Every story links straight to its publisher.
Industry P pharmaphorum
Microsoft outage disrupting healthcare; reports Phil.Taylor Fri, 13/11/2026 - 09:34
Industry P pharmaphorum
Inspection readiness is now a commercial question Nicole.Raleigh Fri, 13/11/2026 - 09:30
Industry
Pharmaceutical Technology
Takeda has commercially launched Orzeyful (oveporexton) in the US as a prescription treatment for adult patients with narcolepsy type 1.
Industry P Pharmafile
Envirogen has been appointed to Lot 6, covering reverse osmosis (RO), of the national Decontamination Equipment, Maintenance and Associated Accessories framework managed by Public Services Delivery Scotland (PSD Scotland). Announced on 1 October 2026 through Public Contracts Scot…
Industry
Labiotech
Gene editing has spent the last decade proving what's possible in the lab. The next decade is about proving it can reach the patients who need it most. The post Inside Arbor’s CNS pipeline and next-generation gene editing appeared first on Labiotech.eu. © Labiotech UG and Labiote…
Industry
European Biotechnology
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: Gubra fires its CEO, Commit strengthens its leadership as its first candidate prepares to enter the clinic and TECr…
Industry S Science News
New fossil survey shines light on this mysterious creature, as well as ancient camels’ ecological importance
Industry I In the Pipeline
A number of people have asked me about Anthropic’s Dario Amodei and his statement in a recent video presentation that’s part of the runup to their planned IPO). He says (and he’s said stuff like this before) that “. . .cancer, Alzheimer's, heart disease, mental illness — these wi…
Industry
BioCentury
BIOCENTURY | MANAGEMENT TRACKSBMS PARTING WITH PLENGE AMID R&D REORGANIZATIONPlus: Changes at Absci, Alphamab, DaltonTx, and enGene
Industry N Nature Medicine
Industry
Nature Reviews Drug Discovery
Industry N Nature Medicine
Industry
Nature Reviews Drug Discovery
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTGROWING NEOANTIGEN VACCINE PIPELINE TESTS THE MODALITY’S REACHOver 30 personalized vaccine programs explore how design, setting, and manufacturing could broaden benefit beyond the first Phase III win
Industry
Inside Precision Medicine
The NCI pathologist and 2026 AMP honoree discusses her career-defining discoveries made possible by marrying morphology and molecular diagnostics. The post AMP 2026: How Elaine Jaffe Rewrote the Rules of Lymphoma Pathology appeared first on Inside Precision Medicine.
Industry
BioCentury
BIOCENTURY | FINANCEAFTER SPENDING $10B FOR METSERA, PFIZER TURNS TO BLACKSTONE TO FUND OBESITY PROGRAMFirm to supply up to $1.5B as monthly GLP-1R program moves through late-stage testing
Industry
Fierce Pharma
Measurement Everywhere: Why the Future Can’t Be Measured in the Rearview Mirror pesurya Thu, 11/12/2026 - 15:47
Industry
GEN
A study finds that everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried.…
Industry P Pharmaceutical Executive
Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for berobenatide, and Parexel’s Stacy Hurt on how patients’ use of AI is reshaping sponsor communication.
Industry
GEN
The blood-brain barrier keeps most proteins in the bloodstream out of the brain, but not all. The pathways that import them are damaged early in Alzheimer’s disease models, hinting at new ways to treat the disease. The post Neuroprotective Protein Atlas Positions the Blood-Brain…
Industry P pharmaphorum
BMS shakes up R&D under CMO Cristian Massacesi Phil.Taylor Thu, 12/11/2026 - 18:31
Industry
Inside Precision Medicine
An experimental “living medicine” made from genetically engineered bacteria has been able to reduce the thickness of antibiotic-resistant biofilms in the lungs of pigs. The post Inhaled Bacteria Could Fight Against Drug-Resistant Lung Infections appeared first on Inside Precision…
Industry
Inside Precision Medicine
Carrie Haverty and Neha Kumar explore the vital role of genetic counseling in precision medicine, examining how informed guidance helps patients and families understand genetic testing, interpret results, and navigate increasingly personalized healthcare decisions. The post The P…
Industry
BioPharma Dive
The deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.
Industry
STAT Biotech
Pfizer spent up to $10 billion to buy Metsera last year. Now, it’s bringing in private equity behemoth Blackstone to help pay for the deal.
Industry P Pharmaceutical Commerce
In Episode 1, Part 3, Jon Hamrick, Rena Goins and Bob Cochran explain why specialty networks should start small and how to balance access, data and support.
Industry
Inside Precision Medicine
As part of IPM’s annual virtual summit, The State of Precision Medicine, editor in chief Damian Doherty interviewed Becky Quick in the keynote session. Quick discussed her family’s journey and her motivation for launching CNBC Cures. The post CNBC’s Becky Quick’s Personal Reflect…
Industry
Inside Precision Medicine
As part of IPM’s annual virtual summit, The State of Precision Medicine, editor in chief Damian Doherty interviewed Anne Wojcicki in the opening session. Wojcicki discussed 23andMe's evolution to date and some of the current projects the company has been focusing on. The post Ann…
Industry
TechCrunch Biotech and Health
Whoop is launching a social network that lets members share their sleep, recovery and workout data, but the bigger bet is on becoming more of a personal health brand, with CEO Will Ahmed hinting at acquisitions to come.
Industry
Inside Precision Medicine
Saralyn Mark, MD, highlights the importance of accounting for sex-based biological differences and gender-related factors in understanding disease, interpreting clinical evidence and tailoring treatment. Her session explores lessons learnt from space and how these can be translat…
Industry B BioPharm International
Detalimogene voraplasmid produced a 56% complete response rate in BCG-unresponsive bladder cancer, with an estimated 43% of responses lasting a year.
Industry
European Biotechnology
Belgian biotech Lakefront Biotherapeutics, formerly Galapagos, has discontinued its oral TYK2 inhibitor GLPG3667 after analyzing the drug's competitive landscape and holding talks with potential partners. The autoimmune disease drug had met its primary endpoint in a Phase 2 derma…
Industry
Pharmaceutical Technology
Pfizer has an extensive clinical programme for berobenatide, acquired via its $10bn takeover of Metsera.
Industry P Pharmaceutical Executive
Moderna used its 2026 Analyst Day to outline an oncology-driven growth strategy anchored by intismeran and other cancer antigen therapies.
Industry B BioPharm International
Blackstone Life Sciences will fund up to $1.5 billion of development costs through 2028 for Pfizer’s monthly GLP-1 receptor agonist berobenatide, in exchange for milestone payments tied to approval and sales. Pfizer keeps full control of the program.
Industry B BioTechniques
As the year draws to a close, nothing screams ‘winter’ quite like spending hours mulling over what to get your loved ones for the holidays. Well, yet again, we’d like to offer you a gift, too... in the form of our 2026 gift guide! Winter scenes and reads Wildlife Photographer of…
Industry P Pharmaceutical Commerce
In this week’s Pharma Pulse, Lilly brings Zepbound and Foundayo to Hims & Hers, Swisslog Healthcare expands its Tenutō cold storage line, and FDA adds a NAION warning across the GLP-1 class.
Industry P PLOS Biology
by Daniel Liesner, Rémy Luthringer, Lineekela Kandjengo, John J. Bolton, Mark D. Rothman, Myriam Valero, Fabian B. Haas, Susana M. Coelho Many organisms alternate between distinct life stages and can reproduce either sexually or asexually, yet the mechanisms coordinating these de…
Industry P PLOS Biology
by Sahil Luthra, Raha N. Razin, Adam T. Tierney, Lori L. Holt, Frederic Dick Humans and other animals develop remarkable perceptual and cognitive specializations for identifying, differentiating, and acting on classes of ecologically important signals. This expertise is flexible…
Industry P PLOS Biology
by Artoghrul Alishbayli, Karol Przewrocki, Paul van Heumen, Bernhard Englitz Sound detection amidst noise presents an important challenge in audition. Many naturally occurring sounds (rain, wind) can be described and predicted only statistically, so-called sound textures. Previou…